b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">28331929</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>05</Month>\n            <Day>18</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>07</Month>\n            <Day>26</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">2567-689X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>117</Volume>\n                    <Issue>6</Issue>\n                    <PubDate>\n                        <Year>2017</Year>\n                        <Month>06</Month>\n                        <Day>02</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Thrombosis and haemostasis</Title>\n                <ISOAbbreviation>Thromb. Haemost.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Confirmation of longer FIX activity half-life with prolonged sample collection after single doses of nonacog alfa in patients with haemophilia B.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1052-1057</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1160/TH16-10-0765</ELocationID>\n            <Abstract>\n                <AbstractText>A multicentre, single-dose study enrolled 12 previously treated patients with moderately severe to severe (factor IX [FIX] levels \xe2\x89\xa42 IU/dl) haemophilia B to assess FIX pharmacokinetics after nonacog alfa administration and to evaluate the impact of length of sampling time on half-life (t<sub>\xc2\xbd</sub>). After refraining from FIX replacement for four days, patients received 50 IU/kg as an intravenous (IV) infusion over 10\xc2\xa0minutes. Blood samples were collected predose and 0.25, 0.5, 1, 3, 6, 9, 24, 50, 72, and 96\xc2\xa0h post dose. Tolerability and safety were assessed by monitoring adverse events and were subsequently summary tabulated. FIX activity was measured by a one-stage clotting assay with a lower limit of quantification of 0.010\xc2\xa0IU/ml, and inhibitors to FIX were measured using the Bethesda assay. Pharmacokinetic parameters were calculated by noncompartmental analysis and were descriptively summarised. Half-life estimates were calculated first using all available data, then excluding 96-h observations (truncated at 72 h) and, finally, excluding both 72- and 96-h observations (truncated at 50 h). No patient was positive for FIX inhibitors. No treatment-emergent adverse events were reported. Prolonging the duration of the sample collection to 96\xc2\xa0h resulted in a terminal t<sub>\xc2\xbd</sub> estimate of 39.6 \xc2\xb17.4 h in the eight patients aged 18 years and older, which was longer than the estimates obtained using shorter periods of observation: 29.6 \xc2\xb1 5.5 h (truncated at 72 h) and 27.2 \xc2\xb1 7.0 h (truncated at 50 h). To accurately assess an adult patient\'s t<sub>\xc2\xbd</sub>, sampling should be continued for at least 96 h.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Hua</LastName>\n                    <ForeName>Baolai</ForeName>\n                    <Initials>B</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wu</LastName>\n                    <ForeName>Runhui</ForeName>\n                    <Initials>R</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sun</LastName>\n                    <ForeName>FeiFei</ForeName>\n                    <Initials>F</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Luo</LastName>\n                    <ForeName>Binyu</ForeName>\n                    <Initials>B</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Alvey</LastName>\n                    <ForeName>Christine</ForeName>\n                    <Initials>C</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Labadie</LastName>\n                    <ForeName>Robert</ForeName>\n                    <Initials>R</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Qu</LastName>\n                    <ForeName>Peng Roger</ForeName>\n                    <Initials>PR</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Korth-Bradley</LastName>\n                    <ForeName>Joan M</ForeName>\n                    <Initials>JM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Joan M. Korth-Bradley, Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426, USA, Tel.: +1 484 865 2914, Fax: +1 484 865 6457, E-mail: joan.korth-bradley@pfizer.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rendo</LastName>\n                    <ForeName>Pablo</ForeName>\n                    <Initials>P</Initials>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016430">Clinical Trial</PublicationType>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016448">Multicenter Study</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>03</Month>\n                <Day>23</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>Thromb Haemost</MedlineTA>\n            <NlmUniqueID>7608063</NlmUniqueID>\n            <ISSNLinking>0340-6245</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9001-28-9</RegistryNumber>\n                <NameOfSubstance UI="D005164">Factor IX</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001780" MajorTopicYN="N">Blood Coagulation Tests</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005164" MajorTopicYN="N">Factor IX</DescriptorName>\n                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006207" MajorTopicYN="N">Half-Life</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002836" MajorTopicYN="N">Hemophilia B</DescriptorName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>\n                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013048" MajorTopicYN="N">Specimen Handling</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">BeneFIX</Keyword>\n            <Keyword MajorTopicYN="Y">Chinese</Keyword>\n            <Keyword MajorTopicYN="Y">paediatrics</Keyword>\n            <Keyword MajorTopicYN="Y">pharmacokinetics</Keyword>\n            <Keyword MajorTopicYN="Y">recombinant factor IX</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2016</Year>\n                <Month>10</Month>\n                <Day>07</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>03</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>3</Month>\n                <Day>24</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>19</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>3</Month>\n                <Day>24</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">28331929</ArticleId>\n            <ArticleId IdType="pii">16-10-0765</ArticleId>\n            <ArticleId IdType="doi">10.1160/TH16-10-0765</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'